Genetic testing and referral patterns of non-BRCA mutation carriers at increased or uncertain risk of ovarian cancer.

被引:0
|
作者
Lee, Sarah S. [1 ]
Baumann, Katherine [1 ]
Bhuptani, Bhoomi [1 ]
Turecamo, Sarah [1 ]
Smith, Julia Anne [1 ]
Pothuri, Bhavana [1 ]
机构
[1] NYU, Sch Med, New York, NY USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1585
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Ovarian cancer risk-reduction and screening in BRCA 1/2 mutation carriers
    DiSilvestro, Jessica
    Dexter, Julia
    Haddad, Jessica
    Beffa, Lindsey
    Raker, Christina
    Laprise, Jessica
    Wilbur, Jennifer Scalia
    Clark, Melissa
    Bradford, Leslie
    Brown, Amy
    Hofstatter, Erin
    Dalela, Disha
    Toland, Maris
    Robison, Katina
    Stuckey, Ashley
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S195 - S196
  • [42] Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act
    Tschernichovsky, Roi
    Goodman, Annekathryn
    ONCOLOGIST, 2017, 22 (04): : 450 - 459
  • [43] Patterns of care and outcomes of risk reducing surgery in women with pathogenic variants in non-BRCA and Lynch syndrome ovarian cancer susceptibility genes
    Schwartz, Zachary P.
    Li, Andrew J.
    Walsh, Christine S.
    Rimel, B. J.
    Alvarado, Monica M.
    Lentz, Scott E.
    Cass, Ilana
    GYNECOLOGIC ONCOLOGY, 2023, 173 : 1 - 7
  • [44] Anthropometric Measures and Risk of Ovarian Cancer Among BRCA1 and BRCA2 Mutation Carriers
    McGee, Jacob
    Kotsopoulos, Joanne
    Lubinski, Jan
    Lynch, Henry T.
    Rosen, Barry
    Tung, Nadine
    Kim-Sing, Charmaine
    Karlan, Beth
    Foulkes, William D.
    Ainsworth, Peter
    Ghadirian, Parviz
    Senter, Leigha
    Eisen, Andrea
    Sun, Ping
    Narod, Steven A.
    OBESITY, 2012, 20 (06) : 1288 - 1292
  • [45] Hormone replacement therapy and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Kotsopoulos, J
    Lubinski, J
    Neuhausen, SL
    Lynch, HT
    Rosen, B
    Ainsworth, P
    Moller, P
    Ghadirian, P
    Isaacs, C
    Karlan, B
    Sun, P
    Narod, SA
    GYNECOLOGIC ONCOLOGY, 2006, 100 (01) : 83 - 88
  • [46] IMPACT OF PREGNANCY ON THE RISK OF BREAST AND OVARIAN CANCER IN BRCA1 AND BRCA2 MUTATION CARRIERS
    Russo, M.
    Corvetto, E.
    Fais, M.
    Candotti, G.
    Locati, V.
    Proto, A.
    Angioni, S.
    Carcassi, C.
    Mais, V.
    Peiretti, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A391 - A391
  • [47] ASPIRIN USE AND RISK OF OVARIAN CANCER AMONG BRCA1 AND BRCA2 MUTATION CARRIERS
    Kotsopoulos, J.
    Lubinski, J.
    Demsky, R.
    Kim-Sing, C.
    Tung, N.
    Karlan, B.
    Sun, P.
    Narod, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1553 - 1553
  • [48] Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Kotsopoulos, Joanne
    Lubinski, Jan
    Gronwald, Jacek
    Cybulski, Cezary
    Demsky, Rochelle
    Neuhausen, Susan L.
    Kim-Sing, Charmaine
    Tung, Nadine
    Friedman, Susan
    Senter, Leigha
    Weitzel, Jeffrey
    Karlan, Beth
    Moller, Pal
    Sun, Ping
    Narod, Steven A.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (05) : 1136 - 1146
  • [49] ASPIRIN USE AND RISK OF OVARIAN CANCER AMONG BRCA1 AND BRCA2 MUTATION CARRIERS
    Kotsopoulos, J.
    Lubinski, J.
    Demsky, R.
    Kim-Sing, C.
    Tung, N.
    Karlan, B.
    Sun, P.
    Narod, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 308 - 308
  • [50] BRCA testing of breast cancer patients: medical specialists' referral patterns, knowledge and attitudes to genetic testing
    van Riel, E.
    Warlam-Rodenhuis, C. C.
    Verhoef, S.
    Rutgers, E. J. Th.
    Ausems, M. G. E. M.
    EUROPEAN JOURNAL OF CANCER CARE, 2010, 19 (03) : 369 - 376